These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16206512)

  • 21. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis.
    Geier DA; Geier MR
    Hepatogastroenterology; 2002; 49(48):1571-5. PubMed ID: 12397738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study.
    Gaggar A; Coeshott C; Apelian D; Rodell T; Armstrong BR; Shen G; Subramanian GM; McHutchison JG
    Vaccine; 2014 Sep; 32(39):4925-31. PubMed ID: 25045824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.
    Jacques P; Moens G; Desombere I; Dewijngaert J; Leroux-Roels G; Wettendorff M; Thoelen S
    Vaccine; 2002 Nov; 20(31-32):3644-9. PubMed ID: 12399191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
    Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
    Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.
    van den Ende C; Marano C; van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):789-809. PubMed ID: 28586278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination safety.
    Geier MR; Geier DA
    Ann Pharmacother; 2002 Mar; 36(3):370-4. PubMed ID: 11895045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.
    Osiowy C
    Hum Vaccin Immunother; 2018; 14(8):2093-2097. PubMed ID: 29641290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events after hepatitis A B combination vaccine.
    Woo EJ; Miller NB; Ball R;
    Vaccine; 2006 Mar; 24(14):2685-91. PubMed ID: 16310295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal anti-HBVs suppress the immune response of infants to hepatitis B vaccine.
    Chen X; Gui X; Zhang L; Huang F; Zhong H; Pang Z; Wang S; Tang L; Fu L; Peng Y; Shellman Y
    J Viral Hepat; 2016 Dec; 23(12):955-960. PubMed ID: 27469237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal route favors the induction of CD4
    Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
    Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status.
    Mathew JL; El Dib R; Mathew PJ; Boxall EH; Brok J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006481. PubMed ID: 18677780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China.
    Zhang X; Wang J; Chen X; Yu M; Yu S; Sun Y; Duan J; Sun H; Yuan P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30201691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic adverse effects of hepatitis B vaccines are rare.
    Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.